Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome
- 1 June 1990
- journal article
- case report
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 19 (6) , 313-328
- https://doi.org/10.1016/0049-0172(90)90069-r
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Peripheral neuropathy associated with eosinophilia-myalgia syndromeAnnals of Neurology, 1990
- Eosinophilia-myalgia linked with L-tryptophanThe Lancet, 1990
- Interim Guidance on the Eosinophilia-Myalgia SyndromeAnnals of Internal Medicine, 1990
- Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndromeAnnals of Neurology, 1989
- Mast cells, T cells and abnormal fibrosisImmunology Today, 1985
- Clinical Epidemiology of Toxic-Oil SyndromeNew England Journal of Medicine, 1983
- HLA-DR3, DR4 INCREASE IN CHRONIC STAGE OF SPANISH OIL DISEASEThe Lancet, 1982
- Development of a Scleroderma-like Illness during Therapy with L-5-Hydroxytryptophan and CarbidopaNew England Journal of Medicine, 1980
- Diffuse fasciitis with eosinophiliaThe American Journal of Medicine, 1980
- Scleroderma-like Lesions and the Carcinoid SyndromeArchives of internal medicine (1960), 1973